Authors

• Laurence Belkoff (ORCID: https://orcid.org/0000-0003-2789-6815)
• David S. Morris (ORCID: https://orcid.org/0000-0003-2120-4590)
• Curtis Dunshee (ORCID: https://orcid.org/0000-0002-3088-8309)
• Paul Sieber (ORCID: https://orcid.org/0000-0002-6064-9683)
• Elan Diamond
• Mike Ufer (ORCID: https://orcid.org/0000-0002-6637-4406)
• Kriti Mittal (ORCID: https://orcid.org/0000-0001-9996-2012)
• Kevin D. Courtney (ORCID: https://orcid.org/0000-0001-6273-3144)
• Michael Goodman (ORCID: https://orcid.org/0000-0001-6320-9707)
• Ronald Tutrone (ORCID: https://orcid.org/0000-0001-6705-778X)
• Michael J. Ryan (ORCID: https://orcid.org/0000-0002-5679-6031)
• James D’Olimpio
• Neal D. Shore (ORCID: https://orcid.org/0000-0001-5767-0548)
• Yi Zhong (ORCID: https://orcid.org/0000-0003-3551-2180)
• Jose De La Cerda (ORCID: https://orcid.org/0009-0008-6036-5753)
• Lawrence Gervasi

Institutions

• Southwest General Health Center (US)
• SUNY Old Westbury (US)
• University of Massachusetts Chan Medical School (US)
• Pfizer (United States) (US)
• Urology San Antonio (US)
• Southwestern Medical Center (US)
• Urology Associates (US)
• New Jersey Urology (US)
• Arizona Pain Specialists (US)
• Primary Health Care (QA)
• Sumitomo Dainippon Pharma (United States) (US)
• Chesapeake Urology Associates (US)
• Nashville Oncology Associates (US)
• Dermatology Specialists (US)
• Carolina Urologic Research Center (US)
• Southwestern Medical Center (US)
• Wake Forest University (US)
• The University of Texas Southwestern Medical Center (US)

Publication Details

Journal

Targeted Oncology

Published

2025-04-04

DOI

https://doi.org/10.1007/s11523-025-01139-3

Citations

3

Primary Topic

Prostate Cancer Treatment and Research

Type

article

Field-Weighted Citation Impact

4.56

Funders

• Pfizer